| Financial Year |
March 31 2023 |
| Monetary Funds |
936,202,310.31 |
| Held-for-trading Financial Assets |
167,731,279.02 |
| Notes Receivable |
63,484,870.17 |
| Accounts Receivable |
474,262,843.28 |
| Advances to Suppliers |
308,156,806.26 |
| Other Receivables |
10,359,819.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,137,106,806.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
41,427,063.26 |
| Total Current Assets |
4,229,226,811.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
58,482,027.62 |
| Investment Properties |
-- |
| Fixed Assetes |
885,088,873.89 |
| Under-construction Projects |
81,677,625.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
209,860,742.48 |
| R&D expenses |
-- |
| Goodwill |
1,042,371,964.24 |
| Long-Term Deferred and Prepaid Expenses |
5,987,171.97 |
| Deferred Income Tax Assets |
37,478,674.68 |
| Other Non-Current Assets |
58,964,029.56 |
| Sub-Total of Non-Current Assets |
2,423,951,329.07 |
| Total Assets |
6,653,178,140.95 |
| Short-Term Loans |
666,435,702.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
225,570,471.20 |
| Accounts Payable |
846,974,474.31 |
| Accounts Received In Advance |
7,262,380.35 |
| Employee Compensation Payable |
26,808,449.42 |
| Taxes Payable |
28,767,039.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,127,703.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,828,739.19 |
| Other Current Liabilities |
13,809,940.72 |
| Sub-Total of Current Liabilities |
1,989,783,209.67 |
| Long-term Loans |
200,100,000.00 |
| Bonds Payable |
386,885,999.79 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
29,069,241.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
655,769,287.70 |
| Total Liabilities |
2,645,552,497.37 |
| Paid-In Capital(Or Share Stock) |
581,951,198.00 |
| Capital Surplus |
1,636,047,532.43 |
| Surplus Reserve |
111,418,743.11 |
| LESS:Treasury Stock |
54,688,745.70 |
| Undistributed Profits |
1,518,917,775.99 |
| Minority Stockholder's Interest |
90,221,549.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,917,404,094.10 |
| Owner's Equity（Stockholder's Equity） |
4,007,625,643.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,653,178,140.95 |
